Biovista President Dr. Aris Persidis will be presenting at the 3rd Annual Drug repositioning, rescue and repurposing conference to be held July 15-16 in Boston MA. This conference will highlight the latest developments in the fields of drug repositioning, repurposing and rescue. This conference will cover cover therapy development with the involvement of patient advocacy efforts … Read More
In an ideal world we shouldn’t need drug repositioning. In an ideal world we would know exactly how drugs work, we would have precision medicine and no need to find alternative indications. But we don’t live in an ideal world, not even an almost ideal one. And so for now, there seems to be a role for drug repositioning and even more so for systematic drug repositioning (SDR). But is SDR currently done in the best possible way? What about the art of SDR -how can we integrate SDR within an organization with minimum disruption to existing processes? And could SDR evolve to become a systematic discovery tool?